Connection

Evangelos Terpos to Health Expenditures

This is a "connection" page, showing publications Evangelos Terpos has written about Health Expenditures.
Connection Strength

0.025
  1. A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America. J Med Econ. 2018 May; 21(5):525-536.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.